share_log

Vanda Pharmaceuticals Sees FY22 Sales $240M-$280M Vs. $265.1M Est.

Vanda Pharmaceuticals Sees FY22 Sales $240M-$280M Vs. $265.1M Est.

万达制药预计2012财年的销售额为2.4亿至2.8亿美元。2.651亿美元。
Benzinga Real-time News ·  2022/08/03 16:30

Vanda Pharmaceuticals Sees FY22 Sales $240M-$280M Vs. $265.1M Est.

万达制药预计2012财年的销售额为2.4亿至2.8亿美元。2.651亿美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发